CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 24 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,000 | 0.0% | 958 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,000 | +28.6% | 958 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $14,000 | -6.7% | 958 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | -6.2% | 958 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $16,000 | +14.3% | 958 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $14,000 | -12.5% | 958 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $16,000 | -5.9% | 958 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $17,000 | 0.0% | 958 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $17,000 | 0.0% | 958 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $17,000 | -10.5% | 958 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $19,000 | +111.1% | 958 | +26.2% | 0.00% | – |
| Q1 2017 | $9,000 | – | 759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PLATINUM INVESTMENT MANAGEMENT LTD | 672,885 | $11,123,000 | 0.26% |
| AWM Investment Company, Inc. | 80,165 | $1,325,000 | 0.25% |
| Nikko Asset Management Americas, Inc. | 532,318 | $8,799,000 | 0.17% |
| ARK Investment Management | 314,378 | $5,197,000 | 0.13% |
| Sumitomo Mitsui Trust Holdings, Inc. | 528,418 | $8,735,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,100 | $531,000 | 0.01% |
| Mizuho Securities Co. Ltd. | 300 | $5,000 | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 148,815 | $2,459,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 18,629 | $308,000 | 0.00% |
| STATE OF WISCONSIN INVESTMENT BOARD | 16,100 | $237,000 | 0.00% |